[10] For patients on warfarin, the main risk is already bleeding or clotting problems
Other Potential Semaglutide Benefits Apart from its primary indications, semaglutide shows potential benefits in other areas: Cardiovascular Benefits in Non-diabetics: Semaglutide has demonstrated favorable effects on cardiovascular outcomes in subjects with or without diabetes, indicating its potential for cardiovascular risk reduction in a broader population [9]
In rare cases, a cardiologist might supervise concurrent use with strict monitoring, but this is not standard practice
But that aside for a moment, what I would say is that GLP-1 medicines have specific FDA indications
When delivered centrally, SST increases food intake (78, 79)
His contributions are pivotal in advancing the understanding and treatment of neurological diseases